These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38761668)

  • 21. New ideas for therapy in ALS.
    Swash M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Mar; 6(1):3-4. PubMed ID: 16036419
    [No Abstract]   [Full Text] [Related]  

  • 22. Epidemiology of amyotrophic lateral sclerosis and effect of riluzole on disease course.
    Cetin H; Rath J; Füzi J; Reichardt B; Fülöp G; Koppi S; Erdler M; Ransmayr G; Weber J; Neumann K; Hagmann M; Löscher WN; Auff E; Zimprich F
    Neuroepidemiology; 2015; 44(1):6-15. PubMed ID: 25571962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.
    Ludolph AC; Schuster J; Dorst J; Dupuis L; Dreyhaupt J; Weishaupt JH; Kassubek J; Weiland U; Petri S; Meyer T; Grosskreutz J; Schrank B; Boentert M; Emmer A; Hermann A; Zeller D; Prudlo J; Winkler AS; Grehl T; Heneka MT; Wollebæk Johannesen S; Göricke B;
    Lancet Neurol; 2018 Aug; 17(8):681-688. PubMed ID: 29934198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-benefit analysis of riluzole for the treatment of amyotrophic lateral sclerosis.
    Ginsberg GM; Lev B
    Pharmacoeconomics; 1997 Nov; 12(5):578-84. PubMed ID: 10174324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adverse efects of riluzole (Rilutek) in the treatment of amyotrophic lateral sclerosis].
    Roch-Torreilles I; Camu W; Hillaire-Buys D
    Therapie; 2000; 55(2):303-12. PubMed ID: 10967703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiological and clinical factors impact on the benefit of riluzole in the survival rates of patients with ALS.
    Fávero FM; Voos MC; Castro I; Caromano FA; Oliveira ASB
    Arq Neuropsiquiatr; 2017 Aug; 75(8):515-522. PubMed ID: 28813081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral Sclerosis.
    Hodgkinson VL; Lounsberry J; Mirian A; Genge A; Benstead T; Briemberg H; Grant I; Hader W; Johnston WS; Kalra S; Linassi G; Massie R; Melanson M; O'Connell C; Schellenberg K; Shoesmith C; Taylor S; Worley S; Zinman L; Korngut L
    Can J Neurol Sci; 2018 Nov; 45(6):652-659. PubMed ID: 30430962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Cochrane Database Syst Rev; 2002; (2):CD001447. PubMed ID: 12076411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Moore DH
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD001447. PubMed ID: 22419278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Cochrane Database Syst Rev; 2007 Jan; (1):CD001447. PubMed ID: 17253460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic concepts in Amyotrophic Lateral Sclerosis (ALS)].
    Ludolph AC
    Drug Res (Stuttg); 2013 Nov; 63 Suppl 1():S21. PubMed ID: 24242034
    [No Abstract]   [Full Text] [Related]  

  • 32. Riluzole exerts transient modulating effects on cortical and axonal hyperexcitability in ALS.
    Geevasinga N; Menon P; Ng K; Van Den Bos M; Byth K; Kiernan MC; Vucic S
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):580-588. PubMed ID: 27249331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Riluzole.
    Gelinas DF
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Dec; 1 Suppl 4():3-4. PubMed ID: 11466957
    [No Abstract]   [Full Text] [Related]  

  • 34. High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study.
    Graf M; Ecker D; Horowski R; Kramer B; Riederer P; Gerlach M; Hager C; Ludolph AC; Becker G; Osterhage J; Jost WH; Schrank B; Stein C; Kostopulos P; Lubik S; Wekwerth K; Dengler R; Troeger M; Wuerz A; Hoge A; Schrader C; Schimke N; Krampfl K; Petri S; Zierz S; Eger K; Neudecker S; Traufeller K; Sievert M; Neundörfer B; Hecht M;
    J Neural Transm (Vienna); 2005 May; 112(5):649-60. PubMed ID: 15517433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjunctive modafinil in ALS.
    Sternbach H
    J Neuropsychiatry Clin Neurosci; 2002; 14(2):239. PubMed ID: 11983803
    [No Abstract]   [Full Text] [Related]  

  • 36. Disease-modifying treatment of amyotrophic lateral sclerosis.
    Schultz J
    Am J Manag Care; 2018 Aug; 24(15 Suppl):S327-S335. PubMed ID: 30207671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Riluzole 5 mg/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosis.
    Dyer AM; Smith A
    Drug Des Devel Ther; 2017; 11():59-64. PubMed ID: 28053507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Riluzole Exhibits No Therapeutic Efficacy on a Transgenic Rat model of Amyotrophic Lateral Sclerosis.
    Chen S; Liao Q; Lu K; Zhou J; Huang C; Bi F
    Curr Neurovasc Res; 2020; 17(3):275-285. PubMed ID: 32271694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic lateral sclerosis (LiCALS) [Eudract number: 2008-006891-31].
    Al-Chalabi A; Shaw PJ; Young CA; Morrison KE; Murphy C; Thornhill M; Kelly J; Steen IN; Leigh PN;
    BMC Neurol; 2011 Sep; 11():111. PubMed ID: 21936930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical trials of riluzole in patients with ALS. ALS/Riluzole Study Group-II.
    Miller RG; Bouchard JP; Duquette P; Eisen A; Gelinas D; Harati Y; Munsat TL; Powe L; Rothstein J; Salzman P; Sufit RL
    Neurology; 1996 Oct; 47(4 Suppl 2):S86-90; discussion S90-2. PubMed ID: 8858057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.